Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous lymphoplasmacytic lymphoma

J I Allbritton1, T D Horn

  • 1Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.

Journal of the American Academy of Dermatology
|May 20, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T-helper immune phenotype may underlie 'paradoxical' tumour necrosis factor-α inhibitor therapy-related psoriasiform dermatitis.

Clinical and experimental dermatology·2017
Same author

Dicer and micro-RNAs in cutaneous disease.

Journal of cutaneous pathology·2009
Same author

Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis.

Kidney international·2008
Same author

Histological study of necrolytic acral erythema.

The Journal of the Arkansas Medical Society·2004
Same author

Yellow eyelids heralding lymphoma.

Dermatology nursing·2002
Same author

Granuloma annulare: another manifestation of Bartonella infection?

The American Journal of dermatopathology·2002

This case study highlights a rare cutaneous lymphoplasmacytic lymphoma that recurred multiple times but remained localized. Effective management with radiotherapy, excision, and chemotherapy controlled the indolent disease over nine years.

Area of Science:

  • Dermatology
  • Oncology
  • Hematology

Background:

  • Lymphoplasmacytic lymphoma is a rare neoplastic proliferation.
  • Cutaneous involvement can present as extramedullary plasmacytomas.
  • Understanding indolent variants is crucial for patient management.

Observation:

  • A patient presented with recurrent cutaneous lymphoplasmacytic lymphoma.
  • Disease recurrences were managed with local radiotherapy, surgical excision, and low-dose chemotherapy.
  • The patient experienced no extracutaneous spread over a nine-year period.

Findings:

  • The case illustrates the indolent behavior of cutaneous extramedullary plasmacytomas.
  • Localized treatment modalities were effective in controlling the disease.

Related Experiment Videos

  • Prolonged disease control without systemic involvement was achieved.

    • Implications:

    • Cutaneous extramedullary plasmacytomas can exhibit an indolent clinical course.
    • Multimodal localized therapy can achieve long-term remission.
    • This case expands the understanding of rare cutaneous lymphomas.